NCT00893516Phase 2Terminated

CD4 in Combination With CHOP in Treating Non-cutaneous Peripheral TCell Lymphoma

Study sponsor: Emergent BioSolutions

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2008-10Actual
Enrollment · participants5Actual
Source updated2026-10-07Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.